We found that WPW can exert its therapeutic effect on RA by inhibiting the expression of pro-inflammatory cytokines IL-6, IL-17, IL-1β and promoting the expression of anti-inflammatory cytokines IL-4 and IL-10. The gene discussed is IL1B; the disease is rheumatoid arthritis.